Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells

Journal of Lipid Research

Volumn 47, Issue 2, 2006, Pages 393-403

  Jackson, Kim G ^a   Maitin, Vatsala ^a   Leake, David S ^a   Yaqoob, Parveen ^a   Williams, Christine M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Apolipoprotein C III; Apolipoprotein E; Low density lipoprotein receptor; Low density lipoprotein receptor related protein 1; Monounsaturated fatty acids; Polyunsaturated fatty acids; Real time reverse transcription polymerase chain reaction

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HEPARIN; IODINE 125; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MONOUNSATURATED FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN ANTIBODY; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DEGRADATION; FAT INTAKE; FLOTATION; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID COMPOSITION; LIPID LIVER LEVEL; LIPOGENESIS; MALE; NUCLEOTIDE SEQUENCE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN ISOLATION; RADIOACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES, MONOCLONAL; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; BINDING, COMPETITIVE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHOLESTEROL; CHYLOMICRONS; DIETARY FATS; DIETARY FATS, UNSATURATED; ENDOCYTOSIS; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LDL-RECEPTOR RELATED PROTEIN 1; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROPROTEIN CONVERTASES; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; STEROL O-ACYLTRANSFERASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 33244493738     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500382-JLR200     Document Type: Article

References (47)

1. Patsch, J. R. 1992. Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis. 106: 83-97.
2. Blum, C. B. 1982. Dynamics of apolipoprotein E metabolism in humans. J. Lipid Res. 23: 1308-1316.
3. Jong, M. C., M. H. Hofker, and L. M. Havekes. 1999. Role of apoCs in lipoprotein metabolism. Functional differences between apo C1, apo C2 and apo C3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
4. Jackson, K. G., E. J. Wolstencroft, P. A. Bateman, P. Yaqoob, and C. M. Williams. 2005. Greater enrichment of triacylglycerol-rich lipoproteins with apolipoproteins E and C-III after meals rich in saturated fatty acids than after meals rich in unsaturated fatty acids. Am. J. Clin. Nutr. 81: 25-34.
5. Dashti, D., and G. Wolfbauer. 1986. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2. Biochim. Biophys. Acta. 875: 473-486.
6. Mulder, M., E. de Wit, and L. M. Havekes. 1991. The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2. Biochim. Biophys. Acta. 1081: 308-314.
7. Bohnet, K., T. Pillot, S. Visvikis, N. Sabolovic, and G. Siest. 1996. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J. Lipid Res. 37: 1316-1324.
8. Quaschning, T., M. Koniger, A. Kramer-Guth, S. Greiber, H. Pavenstadt, M. Nauck, P. Schollmeyer, and C. Wanner. 1997. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells. Nephrol. Dial. Transplant. 12: 2528-2536.
9. Truong, T. Q., L. Falstrault, C. Tremblay, and L. Brissette. 1999. Low density lipoprotein-receptor plays a major role in the binding of very low density lipoproteins and their remnants on HepG2 cells. Int. J. Biochem. Cell Biol. 31: 695-705.
10. Mamotte, C. D. S., M. Sturm, J. I. Foo, F. M. Van Bockxmeer, and R. R. Taylor. 1999. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am. J. Physiol. 276: E553-E557.
11. Mun̈oz, S., M. Merlos, D. Zambón, C. Rodriguez, J. Sabaté, E. Ros, and J. C. Laguna. 2001. Walnut-enriched diet increases the association of LDL from hypercholesterolaemic men with human HepG2 cells. J. Lipid Res. 42: 2069-2076.
12. Wong, S. H., and P. J. Nestle. 1987. Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL to HepG2 cells. Atherosclerosis. 64: 139-146.
13. Lindsey, S. A., A. Pronczuk, and C. Hayes. 1992. Low density lipoproteins from humans supplemented with n-3 fatty acids depress both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. J. Lipid Res. 33: 647-658.
14. Cho, B. H. S., R. Choue Dokko, and B. Hong Chung. 2002. Oleic, linoleic and linolenic acids enhance receptor-mediated uptake of low density lipoproteins in Hep-G2 cells. J. Nutr. Biochem. 13: 330-336.
15. Pal, S., A. M. Thomson, C. D. K. Bottema, and P. D. Roach. 2002. Polyunsaturated fatty acids downregulate the low density lipoprotein receptor of human HepG2 cells. J. Nutr. Biochem. 13: 55-63.
16. Yu-Poth, S., D. Yin, G. Zhao, P. M. Kris-Etherton, and T. D. Etherton. 2004. Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells. J. Nutr. 134: 68-71.
17. Javitt, N. B. 1990. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol and bile acids. FASEB J. 4: 161-168.
18. Karpe, F., and A. Hamsten. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35: 1311-1317.
19. Edelstein, C., and M. Scanu. 1986. Precautionary measures for collecting blood destined for lipoprotein isolation. Methods Enzymol. 128: 151-155.
20. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
21. Leake, D. S., and S. M. Rankin. 1990. The oxidative modification of low-density lipoproteins by macrophages. Biochem. J. 270: 741-748.
22. Schacterle, G. R., and R. L. Pollack. 1973. A simplified method for the quantitative assay of small amounts of biologic material. Anal. Biochem. 51: 654-655.
23. Weisgraber, K. H., T. L. Innerarity, K. J. Harder, R. W. Mahley, R. W. Milne, Y. L. Marvel, and J. T. Sparrow. 1983. The receptor-binding domain of human apolipoprotein E: monoclonal antibody inhibition of binding. J. Biol. Chem. 258: 12348-12354.
24. Pfaffl, M. W. 2001. A new mathematical model for the relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: 2002-2007.
25. Jackson, K. G., E. J. Wolstencroft, P. A. Bateman, P. Yaqoob, and C. M. Williams. Apolipoprotein E enrichment of immunoseparated chylomicron and chylomicron remnants following saturated fatty acids. Nutr. Metab. Cardiovasc. Dis. In press.
26. Gianturco, S. H., F. B. Brown, A. M. Gotto, Jr., and W. A. Bradley. 1982. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J. Lipid Res. 23: 984-993.
27. Bradley, W. A., S-L. C. Huang, J. B. Karlin, A. H. Y. Lin, S. C. Prasad, A. M. Gotto, Jr., and S. H. Gianturco. 1984. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic verylow density lipoprotein to low-density lipoproteins. J. Biol. Chem. 259: 14728-14735.
28. Bradley, W. A., and S. H. Gianturco. 1986. ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apo B is unnecessary. J. Lipid Res. 27: 40-48.
29. Chappel, D. A., G. L. Fry, M. A. Waknitz, L. E. Muhonen, and M. W. Pladet. 1993. Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro. J. Biol. Chem. 268: 25487-25493.
30. Björkegren, J., F. Karpe, S. Vitols, P. Tornvall, and A. Hamsten. 1998. Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro. J. Lipid Res. 38: 423-436.
31. Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler. Thromb. Vasc. Biol. 15: 963-971.
32. Eisenberg, S., G. Friedman, and T. Vogel. 1988. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3. Arteriosclerosis. 8: 480-487.
33. Gianturco, S. H., and W. A. Bradley. 1999. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects. Clin. Cardiol. 22: II-7-II-14.
34. Evans, A. J., C. G. Sawyez, B. M. Wolfe, and M. W. Huff. 1992. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoprotein. J. Biol. Chem. 267: 10743-10751.
35. Clavey, V., G. Agnani, J. M. Bard, S. Lestaveldelattre, and J. C. Fruchart. 1991. Interactions between the LDL receptor and the lipoproteins containing apo-B (in French). Ann. Endocrinol. 52: 459-463.
36. Osbourne, T. F. 2000. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275: 32379-32382.
37. Worgall, T. S., S. L. Sturley, T. Seo, T. F. Osbourne, and R. J. Deckelbaum. 1998. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273: 25537-25540.
38. Hannah, V. C., J. Ou, A. Luong, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms inHEK-293 cells. J. Biol. Chem. 276: 4365-4372.
39. Ou, J. F., H. Tu, B. Shan, A. Luk, R. A. BeBose-Boyd, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98: 6027-6032.
40. Lin, J., R. Yang, P. T. Tarr, P-H. Wu, C. Handschin, S. Li, W. Yang, L. Pei, M. Uldry, P. Tontonoz, C. B. Newgard, and B. M. Spiegelman. 2005. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP. Cell. 120: 261-273.
41. Véniant, M. M., C. H. Zlot, R. L. Walzem, V. Pierotti, R. Driscoll, D. Dichek, J. Herz, and S. G. Young. 1998. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B-48-only" and "Apo-B-100-only" mice. J. Clin. Invest. 102: 1559-1568.
42. Mahley, R. W., and Z-S. Ji. 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40: 1-16.
43. f 20-60 lipoprotein fractions reveals novel findings with respect to the effects of dietary fatty acids on triglyceride-rich lipoproteins in postmenopausal women. Clin. Sci. 103: 227-237.
44. Lambert, M. S., M. A. Avella, Y. Berhane, E. Shervill, and K. M. Botham. 2001. The fatty acid composition of chylomicron remnants influences their binding and internalization by isolated hepatocytes. Eur. J. Biochem. 268: 3983-3992.
45. Xu, J., M. T. Nakamura, H. P. Cho, and S. D. Clarke. 1999. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids - a mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fatty acids. J. Biol. Chem. 274: 23577-23583.
46. Vasandani, C., A. I. Kafrouni, A. Caronna, Y. Bashmakov, M. Gotthardt, J. D. Horton, and D. K. Spady. 2002. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J. Lipid Res. 43: 772-784.
47. Heath, R. B., F. Karpe, R. W. Milne, G. C. Burdge, S. A. Wootton, and K. N. Frayn. 2003. Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J. Lipid Res. 44: 2065-2072.